News Release about NAPIGEN’s publication, "Cas9/gRNA-mediated genome editing of yeast mitochondria and Chlamydomonas chloroplasts”, appeared in the open-access, peer-reviewed journal PeerJ-Life and Environment (PeerJ 8:e8362 https://t.co/WCdGjRdT36). See: https://t.co/B4LYX4kDFt
NAPIGEN now has a peer-reviewed paper published: Cas9/gRNA-mediated genome editing of yeast mitochondria and Chlamydomonas chloroplasts. It’s viewable under DOI 10.7717/peerj.8362.
NAPIGEN unleashes the power of mitochondria. Our genome technology is ready for various business applications such as in industrial biotech, human gene therapy and agriculture by creating high yielding crop plants. #wheat#genomeediting#CRISPR#futureoffood
NAPIGEN thanks the 2019 BIO International Convention for being selected to present at the Start-Up Stadium event in Philadelphia. Presentation will be on Tuesday, June 4, at 4:00 p.m. See you there! #Bio International Convention #wheat#genomeediting#CRISPR#futureoffood